GIORDANO, Giulia Maria
 Distribuzione geografica
Continente #
EU - Europa 5.532
AS - Asia 2.801
NA - Nord America 2.450
SA - Sud America 400
AF - Africa 32
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 11.218
Nazione #
RU - Federazione Russa 4.010
US - Stati Uniti d'America 2.390
SG - Singapore 971
CN - Cina 526
IT - Italia 489
IE - Irlanda 480
HK - Hong Kong 467
BR - Brasile 334
VN - Vietnam 290
KR - Corea 174
GB - Regno Unito 130
DE - Germania 113
JP - Giappone 111
IN - India 84
FR - Francia 65
TR - Turchia 64
UA - Ucraina 44
BD - Bangladesh 42
GR - Grecia 41
FI - Finlandia 37
CA - Canada 26
MX - Messico 24
SE - Svezia 24
AT - Austria 21
AR - Argentina 20
NL - Olanda 18
ES - Italia 15
ZA - Sudafrica 15
IQ - Iraq 13
EC - Ecuador 11
PL - Polonia 9
CL - Cile 8
CH - Svizzera 7
CO - Colombia 7
PK - Pakistan 7
VE - Venezuela 7
NO - Norvegia 6
PE - Perù 6
SA - Arabia Saudita 6
BE - Belgio 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
MA - Marocco 5
NP - Nepal 5
AZ - Azerbaigian 4
BO - Bolivia 4
EG - Egitto 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
ET - Etiopia 3
IL - Israele 3
MY - Malesia 3
PT - Portogallo 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
AM - Armenia 2
CY - Cipro 2
DK - Danimarca 2
EU - Europa 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
PH - Filippine 2
RO - Romania 2
TH - Thailandia 2
AU - Australia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
DZ - Algeria 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
PA - Panama 1
PS - Palestinian Territory 1
SN - Senegal 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 11.218
Città #
Moscow 1.445
San Jose 500
Dublin 471
Singapore 457
Hong Kong 456
Santa Clara 387
Seoul 171
Ashburn 161
Chandler 155
Ho Chi Minh City 112
Beijing 103
Naples 103
Hefei 99
Jacksonville 98
Aversa 81
Hanoi 65
Princeton 58
Roxbury 58
Istanbul 57
Los Angeles 52
Bengaluru 49
New York 49
Dallas 45
Cambridge 43
The Dalles 30
Caserta 28
Bremen 26
São Paulo 26
Memphis 24
Munich 24
Milan 22
Da Nang 21
Orem 21
Wilmington 19
Des Moines 18
Afragola 17
Medford 17
Rome 15
Helsinki 14
Atlanta 13
Boardman 13
Frankfurt am Main 12
Johannesburg 12
Nuremberg 12
San Francisco 12
Falkenstein 10
Turku 10
Viterbo 10
Lappeenranta 9
Brooklyn 8
Chicago 8
Council Bluffs 8
Haiphong 8
Manchester 8
Mexico City 8
Rio de Janeiro 8
Tokyo 8
Vienna 8
Warsaw 8
Woodbridge 8
Baghdad 7
Brasília 7
Stockholm 7
Toronto 7
Changsha 6
Chennai 6
Hải Dương 6
London 6
Norwalk 6
Belo Horizonte 5
Giugliano in Campania 5
Hamburg 5
Kyiv 5
Madrid 5
Manaus 5
Marzano di Nola 5
Pune 5
Ribeirão Preto 5
Tulsa 5
Bergen 4
Brussels 4
Bến Tre 4
Canoas 4
Denver 4
Etobicoke 4
Guarulhos 4
Guayaquil 4
Hillsboro 4
Houston 4
Jinan 4
Lima region 4
Montreal 4
Nanjing 4
Nova Friburgo 4
Palo Alto 4
Porto Alegre 4
Quito 4
Redwood City 4
Sacramento 4
San Martino 4
Totale 5.990
Nome #
A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa 185
A feasibility, acceptability and validation study of the Italian Version of a new cognitive remediation program for psychotic patients - CIRCuiTS 178
Premorbid academic and social functioning in patients with schizophrenia and its associations with negative symptoms and cognition 171
Aetiopathological mechanisms of negative symptoms in schizophrenia 168
Cognitive Impairment after Post-Acute COVID-19 Infection: A Systematic Review of the Literature 166
A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale 158
'Precision psychiatry' needs to become part of 'personalized psychiatry' 155
Assessment of the role of cognitive control on monetary reward and loss anticipation: An electrophysiological study in subjects with schizophrenia 153
A Multivariate Analysis of Depression Prevalence in Psoriasis Patients: A Cohort Study 152
Effectiveness of a social cognition remediation intervention for patients with schizophrenia: a randomized-controlled study 151
Abnormal bodily experiences detected by Abnormal Bodily Phenomena questionnaire are more frequent and severe in schizophrenia than in bipolar disorder with psychotic features 150
Advances in the understanding of the pathophysiology of schizophrenia and bipolar disorder through induced pluripotent stem cell models 149
Interview Versus Performance Assessment of Cognition as Predictors of Real-World Outcomes in a Large-Scale Cross-Sectional Study in Schizophrenia 147
Avolition and microstructural brain abnormalities in Schizophrenia: Reduced fractional anisotropy in pathways connecting amygdala and insular cortex 147
Avolition-Apathy and White Matter Connectivity in Schizophrenia: Reduced Fractional Anisotropy Between Amygdala and Insular Cortex 145
Accuracy of self-assessment of real-life functioning in schizophrenia 140
Investigating the Relationship between White Matter Connectivity and Motivational Circuits in Subjects with Deficit Schizophrenia: A Diffusion Tensor Imaging (DTI) Study 138
A multivariate approach to investigate the associations of electrophysiological indices with schizophrenia clinical and functional outcome 136
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 136
Electrophysiological Correlates of Reward Anticipation in Subjects with Schizophrenia: An ERP Microstate Study 135
Current limitations in technology-based cognitive assessment for severe mental illnesses: a focus on feasibility, reliability, and ecological validity 135
Autism Rating Scale: A New Tool for Characterizing the Schizophrenia Phenotype 134
Mismatch Negativity and P3a Impairment through Different Phases of Schizophrenia and Their Association with Real-Life Functioning 134
External validation of the five domains of negative symptoms: Focus on cognition, functional capacity, and real-world functioning 133
Correlations between Negative Symptoms and Cognitive Deficits in Individuals at First Psychotic Episode or at High Risk of Psychosis: A Systematic Review 130
Factors influencing the outcome of integrated therapy approach in schizophrenia: A narrative review of the literature 130
The Cognitive Assessment Interview (CAI): Association with neuropsychological scores and real-life functioning in a large sample of Italian subjects with schizophrenia 130
EPA guidance on assessment of negative symptoms in schizophrenia 128
Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses 128
Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia 126
EEG-Based Measures in At-Risk Mental State and Early Stages of Schizophrenia: A Systematic Review 125
Updated perspectives on the clinical significance of negative symptoms in patients with schizophrenia 123
Clinical and psychological factors associated with resilience in patients with schizophrenia: data from the Italian network for research on psychoses using machine learning 123
EPA guidance on treatment of negative symptoms in schizophrenia 122
The relationship between the resting state functional connectivity and social cognition in schizophrenia: Results from the Italian Network for Research on Psychoses 121
Assessment of Negative Symptoms in Schizophrenia: From the Consensus Conference-Derived Scales to Remote Digital Phenotyping 120
Auditory P300 and cognition in schizophrenia: findings from a multicentre study 120
Association of functional genetic variation in PP2A with prefrontal working memory processing 119
Gender Differences in Clinical and Psychosocial Features Among Persons With Schizophrenia: A Mini Review 117
Sex and gender differences in clinical and functional indices in subjects with schizophrenia and healthy controls: Data from the baseline and 4-year follow-up studies of the Italian Network for Research on Psychoses 116
Negative Symptom Domains in Children and Adolescents at Ultra-High Risk for Psychosis: Association with Real-Life Functioning 116
Functional connectivity of the ventral tegmental area and avolition in schizophrenia: A resting state functional MRI study 116
Disorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings 116
Neurobiology of Schizophrenia: Electrophysiological indices 116
Research evidence on the management of the cognitive impairment component of the post-COVID condition: a qualitative systematic review 114
Safety of electroconvulsive therapy (ECT) in pregnancy: a systematic review of case reports and case series 113
Illness-related variables and abnormalities of resting-state brain activity in schizophrenia 112
Resting-State Brain Activity Dysfunctions in Schizophrenia and Their Associations with Negative Symptom Domains: An fMRI Study 112
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 110
VTA-insula connectivity and avolition in subjects with schizophrenia 109
ELECTROPHYSIOLOGICAL CORRELATES OF AVOLITION-APATHY DOMAIN IN SCHIZOPHRENIA 108
DISORGANIZATION AND COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA: A STUDY OF RESTING STATE EEG 108
Investigating the causal pathways among psychopathological variables, cognitive impairment, and real-life functioning in people with schizophrenia 108
Unveiling the Associations between EEG Indices and Cognitive Deficits in Schizophrenia-Spectrum Disorders: A Systematic Review 106
Neuroimaging: Diagnostic boundaries and biomarkers 106
Resting state functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia 105
Corrigendum: Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques (Front. Neurosci., (2020), 14, (632), 10.3389/fnins.2020.00632) 104
Investigating the relationships of p3b with negative symptoms and neurocognition in subjects with chronic schizophrenia 104
Social Cognition Impairments in 22q11.2DS Individuals With and Without Psychosis: A Comparison Study With a Large Population of Patients With Schizophrenia 103
Factors Associated with Real-Life Functioning in Persons with Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses 103
The structure stability of negative symptoms: longitudinal network analysis of the Brief Negative Symptom Scale in people with schizophrenia 102
Persistent negative symptoms in recent-onset psychosis: Relationship to treatment response and psychosocial functioning 101
Current goals of neuroimaging for mental disorders: a report by the WPA Section on Neuroimaging in Psychiatry 101
Functional connectivity of the ventral tegmental area and avolition in subjects with schizophrenia: a resting state functional MRI study 100
Depression and neurocognitive impairment: evaluation of their role as predictors of auditory N100 in schizophrenia 100
EPA guidance on assessment of cognitive impairment in schizophrenia 99
Impact of Reward and Loss Anticipation on Cognitive Control: An Event-Related Potential Study in Subjects With Schizophrenia and Healthy Controls 99
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 98
Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study 98
Joint structural-functional magnetic resonance imaging features are associated with diagnosis and real-world functioning in patients with schizophrenia 96
Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial 94
Relationship between MMN and real-life functioning in subjects with schizophrenia 94
Effects of chronic antipsychotic treatment on neurophysiological correlates of the auditory oddball task in schizophrenia: A preliminary report from a multicentre study 93
Genome-wide association study detected novel susceptibility genes for social cognition impairment in people with schizophrenia 93
Electrophysiological and neurocognitive correlates of the disorganization factor in schizophrenia 90
White matter structural connectivity abnormalities in subjects with deficit schizophrenia: A diffusion tensor imaging study 90
MMN impairment in subjects with schizophrenia among different stages of disease 90
Special Report on the Impact of the COVID-19 Pandemic on Clinical EEG and Research and Consensus Recommendations for the Safe Use of EEG 90
Electrophysiological correlates of negative symptom domains in schizophrenia 89
Inter-rater reliability and psychometric characteristics of the Italian version of the Cognitive Assessment Interview (CAI) 89
Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study 89
Prevalence of mental disorders and related risk factors in refugees and asylum seekers in Campania 87
We are not ready to abandon the current schizophrenia construct, but should be prepared to do so 86
Laryngopharyngeal reflux and psychological distress: a vicious cycle worth investigating 86
P3a and real-life functioning in a sample of chronic schizophrenia subjects 85
The efficacy, feasibility and acceptability of a remotely accessible use of circuits, a computerized cognitive remediation therapy program for schizophrenia: A pilot study 85
Switching Antipsychotic Medications in People with Schizophrenia: A 4-Year Naturalistic Study 84
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 84
EPA Guidance on treatment of cognitive impairment in schizophrenia 84
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 84
The dimensional structure of the Positive and Negative Syndrome Scale in first-episode schizophrenia spectrum disorders: an Exploratory Graph Analysis from the OPTiMiSE trial 83
Negative Symptoms of Schizophrenia and Dopaminergic Transmission: Translational Models and Perspectives Opened by iPSC Techniques 82
Neglected Vulnerabilities in Mental Health: Where Do We Need to Do More? 81
The Brief negative Symptom Scale (BNSS): a systematic review of measurement properties 81
Negative symptoms and social cognition as mediators of the relationship between neurocognition and functional outcome in schizophrenia 78
Social cognition and real-life functioning in patient samples with 22q11.2 deletion syndrome with or without psychosis, compared to a large sample of patients with schizophrenia only and healthy controls 78
Worldwide initiatives aimed to train professionals in the use of the ICD-11 77
Evolution of antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia in the real-life: A 4-year follow-up naturalistic study 76
Understanding the Pathophysiology of Mental Diseases and Early Diagnosis Thanks to Electrophysiological Tools: Some Insights and Empirical Facts 75
European Validation of the Self-Evaluation of Negative Symptoms (SNS): A Large Multinational and Multicenter Study 74
Totale 11.308
Categoria #
all - tutte 38.431
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.431


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022420 5 1 9 12 106 16 14 8 17 71 38 123
2022/2023791 72 23 25 40 66 53 10 28 417 10 19 28
2023/2024468 25 24 37 39 134 46 9 10 7 9 32 96
2024/20251.899 7 19 11 142 263 265 260 147 256 263 136 130
2025/20267.393 343 485 331 302 609 3.749 446 304 241 297 201 85
Totale 11.490